03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
This week, in response to the emergence of COVID-19 hot spots in downstate New York, Governor Cuomo ...
Read More >
We next consider how to create a more effective compliance program involving business ventures. This...
Read More >
On July 10, 2019, the Japan Fair Trade Commission ("JFTC")'s research center, Competition Policy Res...
Read More >
Employers may soon be able to submit Component 2 data to the Equal Employment Opportunity Commission...
Read More >
In re Oracle Corp. Derivative Litig., C.A. No. 2017-0337-SG (Del. Ch. July 9, 2020) - After investi...
Read More >
The gig economy is the future of the workforce, right? Or is it an old concept with a modern twist? ...
Read More >